AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 32 min read$VRSK

Shavel Lee sold $696K of VRSK

Shavel Lee (Chief Executive Officer) sold 3,535 shares of Verisk Analytics, Inc. (VRSK) at $196.94 ($0.70M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Shavel Lee
Published Aug 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

This is a scheduled open-market sale by the CEO under a pre-arranged 10b5-1 plan, with no accompanying corporate, financial, or operational updates in the text.

02

Market read

Traders may note the CEO’s scheduled sale for sentiment/positioning, but there is no new fundamental catalyst in the filing details provided.

03

What to watch

The article does not state total planned volume, whether this sale is part of a larger tranche, or any concurrent insider buys, so the signal strength is uncertain.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-03 (intra-day disclosure)

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Verisk Analytics, Inc.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Verisk CEO Shavel Lee filed a Form 4 selling 3,535 shares at $196.94 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Likely minimal near-term price impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a scheduled open-market sale by the CEO with a pre-arranged 10b5-1 plan, and the article contains no accompanying operational or guidance change.

Market effects

Sector

Insider-sale headlines can slightly influence sentiment across data/analytics peers, but this specific disclosure is company-specific and not sector-resetting.

Regional

No clear regional spillover; US-listed issuer filing only.

Global

Limited global relevance; no deal, regulation, or macro linkage described.

Counterpoint

What could challenge this read

Even with a 10b5-1 plan, repeated or sizable CEO sales can still be read by some traders as a mild bearish sentiment input, especially if liquidity/positioning is tight.

Key entities

  • issuer
    Verisk Analytics, Inc.

    US-listed data analytics company subject of the Form 4 insider transaction.

  • insider
    Shavel Lee

    CEO and director who executed the reported sale.

  • trading mechanism
    10b5-1 plan

    Pre-arranged plan indicating the sale was scheduled rather than discretionary.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

VRSK insider trading history →

Related articles

SEP 8
$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

gurufocus.com2 min
AUG 29
$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

simplywall.st2 min
AUG 28
$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

finance.yahoo.com3 min
AUG 19
$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer

marketscreener.com2 min